http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CL-2014001547-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9635de7aeed126ca8054578edfd11f40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_96ec3985e3ce9b24614fb87bf51a4f12
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-541
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5355
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
filingDate 2014-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f08c664fdaf9e4634095870c5ac19fff
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ca98a3fa03b46c61f55004c70a5e300d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0f4295fe8c11887361be5af3e4ba264e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d282305715c337f5c9f5cd58f09aacff
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_89eb41137c545470f1aef1735a4db91e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c710d1fd77fdf1e39b8b074fa2ab150a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_799cc38c409473572a87ff7303d4bd7d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f132e9f03275312c2d5a8d80e03b7a49
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_abe6d8e5ae9bbae98c3254df5f2e6b87
publicationDate 2014-10-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CL-2014001547-A1
titleOfInvention Compounds derived from benzothienyl-pyrrolotriazine, such as protein tyrosine kinase inhibitors; preparation process of said compounds; pharmaceutical composition that includes them; and its use for the treatment and / or prevention of cancer and tumor diseases.
priorityDate 2011-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410453973
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID89622800

Total number of triples: 31.